About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Infection and Immunity in pediatric patients research group is a multidisciplinary pediatric research group made up of health professionals involved in translational research in the field of pediatric infectious diseases and immunodeficiencies, two related fields in terms of pathophysiology and clinical implications. It is a consolidated research group recognized by the AGAUR and is the only one with the accreditation of the Jeffrey Modell Foundation in research in the field of primary immunodeficiencies throughout the state.
The group was officially created in 2010, belongs to the area of Infectious Diseases and participates in the transversal programs of Advanced Translational Immunology and Rare Diseases and actively participates in national and international competitive projects, carries out multiple academic and industry-linked clinical trials and has increased the number and quality in recent years. In addition, it has its own laboratory specially dedicated to advanced immune studies.
IP: Pere Soler Palacín
IP: Andrea Martín Nalda, Pere Soler Palacín
IP: Antoni Soriano Arandes, Maria Espiau Guarner
IP: Jacques Gabriel Rivière, Pere Soler Palacín
IP: Lucas Moreno Martín-Retortillo Collaborators: Marina Martínez Jiménez, Alfons Macaya Ruíz, Anna Santamaria Margalef, Pere Soler Palacín, Ana Marti Delgado, Sara Mas Assens, Immaculada Hernández Rodríguez Funding agency: Fundación Española Ciencia y Tecnología (FECYT) Funding: 25000 Reference: FCT-24-21771 Duration: 01/09/2025 - 31/08/2026
IP: Pere Soler Palacín Collaborators: Laura Batlle Masó, Maria Cristina Díaz de Heredia Rubio, Roger Colobran Oriol, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Miriam Gonzalez Amores, Janire Perurena Prieto, Andrea Martín Nalda, Lucas Moreno Martín-Retortillo, Jacques Gabriel Rivière Funding agency: Instituto de Salud Carlos III Funding: 179993.75 Reference: AC23_2/00033 Duration: 01/01/2024 - 31/12/2026
IP: Roger Colobran Oriol Collaborators: Romina Dieli Crimi, Aina Aguiló Cucurull, Laura Batlle Masó, Andrea Martín Nalda, Neus Castells Sarret Funding agency: Instituto de Salud Carlos III Funding: 208750 Reference: PI23/00161 Duration: 01/01/2024 - 31/12/2026
IP: Juan Jose Gonzalez Lopez Collaborators: Manuel Hernández González, Jose Angel Rodrigo Pendás, Maria Belén Viñado Perez, Aina Aguiló Cucurull, Alba Mir Cros, Albert Moreno Mingorance, Andrea Martín Nalda, Nuria Serre Delcor, Josep Roca Grande, Laura Batlle Masó Funding agency: Instituto de Salud Carlos III Funding: 123420 Reference: PI21/00132 Duration: 01/01/2022 - 30/06/2026
PhD student: Jorgina Vila Soler Director/s: Carlos Rodrigo Gonzalo de Liria, Andres Antón Pagarolas University: Universitat Autònoma de Barcelona Year: 2023
PhD student: Aurora Fernandez Polo Director/s: Pere Soler Palacín University: Universidad Autònoma de Barcelona Year: 2022
PhD student: Marina García Prat Director/s: Pere Soler Palacín, Roger Colobran Oriol University: Universidad Autònoma de Barcelona Year: 2022
PhD student: Susana Melendo Perez Director/s: Pere Soler Palacín University: Universidad Autònoma de Barcelona Year: 2020
PhD student: Jose Maria Valle T-Figueras Director/s: Pere Soler Palacín University: Universidad Autònoma de Barcelona Year: 2020
PhD student: Natalia Ana Mendoza Palomar Director/s: Pere Soler Palacín, Félix Castillo Salinas University: Universidad Autònoma de Barcelona Year: 2020
PhD student: Maria Teresa Riera Bosch, Maria Teresa Riera Bosch, Maria Teresa Riera Bosch Director/s: Pere Soler Palacín University: Universidad Autònoma de Barcelona Year: 2019
PhD student: Maria Espiau Guarner Director/s: Pere Soler Palacín, Diego Yeste Fernandez University: Universidad Autònoma de Barcelona Year: 2017
PhD student: Isabel Vives Oñós, Isabel Vives Oñós Director/s: Pere Soler Palacín University: Universidad Autònoma de Barcelona Year: 2017
PhD student: Antoni Soriano Arandes Director/s: Mario Marotta Baleriola University: Universitat de Barcelona Year: 2017
PhD student: Marta Dapena Archilés, Marta Dapena Archilés Director/s: Pere Soler Palacín, Antonio Carrascosa Lezcano, Antonio Carrascosa Lezcano University: Universitat de Barcelona Year: 2016
PhD student: Pere Soler Palacín Director/s: Concepción Figueras Nadal University: Universidad Autònoma de Barcelona Year: 2010
PhD student: Concepción Figueras Nadal Director/s: Alfredo Gallart Català University: Universidad Autònoma de Barcelona Year: 2010
PhD student: Pere Soler Palacín Director/s: Concepción Figueras Nadal University: Universidad Autònoma de Barcelona Year: 2007
PhD student: Concepción Figueras Nadal Director/s: University: Universidad Autònoma de Barcelona Year: 2006
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
The project, in which Vall d’Hebron participates, studied the Bimervax® vaccine in immunocompromised individuals and paediatric patients.
The study seeks to better understand blood disorders in children and young people, analyzing the role of immunological alterations to improve diagnosis and treatment.
